Civitas launches Phase 2a Clinical Study of CVT-301

11:35 EDT 19 Jun 2012 | Pharmaceutical Business Review

Civitas Therapeutics that uses the ARCUS respiratory delivery platform in developing transformative therapeutics, has announced the start of Phase 2a clinical trial in Parkinson's patients evaluating CVT-301,an inhaled formulation of levodopa (L-dopa..

Original Article: Civitas launches Phase 2a Clinical Study of CVT-301

More From BioPortfolio on "Civitas launches Phase 2a Clinical Study of CVT-301"

Biotech & Healthcare Channels World News Life Science Events Corporate Database Market Reports Categories

Search BioPortfolio:

Clinical Trials - Daily Updated Database search the latest medical and pharmaceutical trials.

Drugs Database search our comprehensive database of prescription drugs.

Research Literature - Daily Updated Database search biomedical papers and journals.

News Quicklinks

Search Biotech, Medical and Healthcare News

Biotech News by Article Type

Biotech News by Location

BioPortfolio Bloggers

Publishing Your News on BioPortfolio

Recent Visitor News Searches

Searches Linking to this Story

plan 2A with CVT

Latest Biotechnology, Pharmaceutical and Healthcare News

Principal Financial Group Announces Strategic Alliance with Accountable Health, Inc.

Essay was based on incorrect premises and an unproved assumption

The GMC can learn from its institutional racism

Author's reply to Cottrell

Is the GMC one of the untouchables?

Nicholson to step down as chief executive of NHS England

NHS cash props up private health sector as recession cuts private patients' spending

BioPortfolio Limited

Publish Content

Agreements

Tools

Help

This site complies with the HONcode standard for trustworthy health information:
Verify here.

The information provided by BioPortfolio.com is not a substitute for professional medical advice, diagnosis or treatment. The BioPortfolio site is sponsored BioPortfolio Limited with offices at Stafford House, 10 Prince of Wales Road, Dorchester, DT1 1PW, England. If you are a legal copyright holder or a designated agent for such and you believe a post on this website falls outside the boundaries of “Fair Use” and legitimately infringes on your or your client's copyright we may be contacted concerning copyright matters at: priority@bioportfolio.com.
All rights reserved. All other trademarks recognized. Copyright © 1997-2013 BioPortfolio Limited. Site developed by Alacrify Ltd.